CD19+ B-cells in autoantibody-negative limbic encephalitis

Niels Hansen1, Demet Önder2, Kerstin Schwing2

  • 1Department of Epileptology, University of Bonn Medical Center, Venusberg - Campus 1, 53127 Bonn, Germany; Department of Psychiatry and Psychotherapy, University Medicine Goettingen, Von-Siebold-Str. 5, 37075 Goettingen, Germany.

Insights

Increased CD19+ B-cells in cerebrospinal fluid (CSF) and blood-brain barrier impairment are observed in antibody-negative limbic encephalitis (LE). Further research is needed to understand the role of these B-cells in central nervous system (CNS) immunity and treatment strategies.

Area of Science:

  • Neuroimmunology
  • Cellular immunology
  • Epileptology

Background:

  • Temporal lobe epilepsy (TLE) can be caused by limbic encephalitis (LE), a condition with varying immunological profiles.
  • Understanding the immune mechanisms in different LE subtypes is crucial for targeted therapies.

Purpose of the Study:

  • To investigate the cellular immune repertoire in patients with TLE due to LE, differentiating between antibody-negative and antibody-associated LE.
  • To explore the potential of flow cytometry in identifying biomarkers for subtype-specific treatment strategies.

Main Methods:

  • Flow cytometry was used to analyze peripheral blood (PB) and cerebrospinal fluid (CSF) immune cells in 62 TLE patients with LE.
  • Patients were categorized into antibody-negative LE (n=40) and neural autoantibody-positive LE (n=22).
  • Neuropsychological testing, MRI, and EEG were also performed.

Main Results:

  • CD19+ B-cells were significantly elevated in the PB and CSF of antibody-negative LE patients compared to those with intracellular antibody-positive LE.
  • Impaired blood-brain barrier function was more prevalent in antibody-negative LE.
  • No significant differences were found in other measured immune cell subsets (CD138+, CD4+, CD8+, HLA-DR+ cells) between LE groups.

Conclusions:

  • Elevated CD19+ B-cells and blood-brain barrier dysfunction in antibody-negative LE suggest their involvement in the disease.
  • The exact pathogenic role of these B-cells in central nervous system (CNS) immunity remains unclear due to a lack of correlation with clinical parameters.
  • Further studies are warranted to assess the utility of CD19+ B-cells as biomarkers for treatment stratification in LE.
Abstract

Related Concept Videos

Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...